• 1. Improvement of (S)-selective imine reductase GF3546 for the synthesis of chiral cyclic amines
  Yuta Fukawa,Keita Yoshida,Sayaka Degura,Koichi Mitsukura,Toyokazu Yoshida Chem. Commun. 2022 58 13222

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine carboxylic acids and derivatives Pyrrolidine carboxylic acids

Recent Advances in the Application of (S)-Tert-butyl 2-methylpyrrolidine-1-carboxylate (CAS: 137496-71-0) in Chemical Biology and Pharmaceutical Research

The compound (S)-Tert-butyl 2-methylpyrrolidine-1-carboxylate (CAS: 137496-71-0) has recently gained significant attention in chemical biology and pharmaceutical research due to its versatile applications as a chiral building block and intermediate in drug synthesis. This research brief synthesizes the latest findings regarding this important compound, focusing on its synthetic applications, biological relevance, and potential therapeutic implications.

Recent studies have highlighted the compound's crucial role in asymmetric synthesis, particularly in the construction of complex pharmaceutical molecules. A 2023 publication in the Journal of Medicinal Chemistry demonstrated its effectiveness as a key intermediate in the synthesis of novel dopamine receptor modulators, where its stereochemical purity significantly influenced the biological activity of the final compounds. The rigid pyrrolidine scaffold provided by this intermediate was shown to enhance binding affinity while maintaining metabolic stability.

In the field of antimicrobial research, a 2024 study published in Bioorganic & Medicinal Chemistry Letters utilized (S)-Tert-butyl 2-methylpyrrolidine-1-carboxylate as a core structure for developing new quorum sensing inhibitors. The researchers found that derivatives containing this scaffold exhibited potent activity against Pseudomonas aeruginosa biofilm formation, with minimal cytotoxicity to human cells. This suggests potential applications in combating antibiotic-resistant infections.

From a synthetic chemistry perspective, recent advances have focused on improving the production efficiency of 137496-71-0. A 2023 patent application disclosed an innovative continuous flow process that achieves higher yields (up to 92%) and enantiomeric excess (>99%) compared to traditional batch methods. This technological advancement could significantly reduce production costs and make the compound more accessible for large-scale pharmaceutical applications.

The compound's potential in CNS drug development has been particularly noteworthy. Research published in ACS Chemical Neuroscience (2024) demonstrated that analogs derived from (S)-Tert-butyl 2-methylpyrrolidine-1-carboxylate showed promising blood-brain barrier permeability and selective binding to σ-1 receptors, indicating potential applications in neurodegenerative disease treatment. The study emphasized the importance of the tert-butoxycarbonyl (Boc) protecting group in maintaining the desired pharmacological properties.

Looking forward, several research groups are exploring the use of this compound in PROTAC (Proteolysis Targeting Chimera) development. Preliminary results presented at the 2024 American Chemical Society meeting showed that the pyrrolidine scaffold provides optimal linker geometry for targeted protein degradation, particularly in oncology targets. This emerging application could open new avenues for drug discovery in challenging therapeutic areas.

In conclusion, (S)-Tert-butyl 2-methylpyrrolidine-1-carboxylate (137496-71-0) continues to demonstrate significant value across multiple pharmaceutical research domains. Its unique structural features, synthetic versatility, and biological relevance make it an important tool for medicinal chemists. Future research directions likely include further optimization of synthetic routes, exploration of new therapeutic applications, and investigation of structure-activity relationships in various drug classes.

• 370069-29-7(tert-butyl 2-(2-aminoethyl)pyrrolidine-1-carboxylate)
• 887587-47-5(tert-butyl 2-(3-aminopropyl)pyrrolidine-1-carboxylate)
• 157007-54-0(tert-butyl (2R)-2-methylpyrrolidine-1-carboxylate)
• 883864-56-0(Carbamic acid, methyl[cis-4-(1-pyrrolidinyl)cyclohexyl]-,1,1-dimethylethyl ester)
• 239483-03-5(Tert-butyl (2S)-2-(3-hydroxypropyl)pyrrolidine-1-carboxylate)
• 876617-06-0((R)-Tert-butyl 2-ethylpyrrolidine-1-carboxylate)
• 550378-07-9(tert-butyl (2R)-2-(2-aminoethyl)pyrrolidine-1-carboxylate)
• 156038-84-5((S,S)-N-Boc-2,5-dimethylpyrrolidine)
• 1433995-57-3(tert-butyl 2-ethylpyrrolidine-1-carboxylate)
• 1260897-40-2(tert-butyl N-methyl-N-[2-(pyrrolidin-2-yl)ethyl]carbamate)